Introduction {#Sec1}
============

Vertebral fractures (VFs) are among the most frequent and serious osteoporotic fractures \[[@CR1]\]. Osteoporotic VFs must be diagnosed using spinal imaging, which contributes to that only one in three individuals with osteoporotic VF come to clinical attention \[[@CR2]\]. In previous studies, the prevalence of VF among women aged 50 years and over has been estimated to 25% \[[@CR3]\].

The global burden of osteoporotic fracture has been estimated and out of a total 9.0 million osteoporotic fractures in the year 2000, 1.4 million were clinical vertebral fractures \[[@CR4]\]. The European Vertebral Osteoporosis Study revealed that the prevalence of VF in Sweden (among both men and women) was among the highest in the European countries \[[@CR5]\].

VFs are associated with back pain, disability, impaired quality of life, morbidity and mortality \[[@CR6]--[@CR8]\]. In a recent meta-analysis of older osteoporotic patients with and without VFs the physical and mental health-related quality of life (HRQL) was reported to be worse in people with VF \[[@CR9]\]. Individuals with an initial VF have a fivefold increased risk to sustain a subsequent VF the first following year than individuals without VF \[[@CR10]\]. It is therefore of great importance to diagnose individuals with VF, even the asymptomatic ones, in order to be able to provide appropriate treatment, to decrease the risk of subsequent osteoporotic fractures in the spine or at other sites \[[@CR11]\].

Vertebral fracture assessment (VFA) is an established method to detect VF \[[@CR12]--[@CR14]\]. Lateral spine imaging is performed with bone densitometers using single or dual-energy X-ray absorptiometry (DXA) with the benefit of less radiation compared to conventional radiographs \[[@CR12]\]. The sensitivity and specificity is high for moderate and severe VF (87--92% and 93--98%, respectively) but is lower for mild fractures \[[@CR13], [@CR15]\]. However, with improvements of the DXA scanners the last years, also mild fractures can be diagnosed with high accuracy \[[@CR16]\]. Thus, VFA is a method that can be applied in conjunction with a standard clinical osteoporosis evaluation, to diagnose VFs with very little additional radiation and at low cost. Most previous studies investigating associations between prevalent VF and quality of life, morbidity and mortality have used conventional spine radiography to identify fractures \[[@CR6]--[@CR8]\]. Among the studies, reporting use of VFA to diagnose prevalent VFs, just a few have been population-based \[[@CR16]--[@CR18]\]. Kanterewicz et al. found a high prevalence (17%) of minor vertebral deformities and that the prevalence of osteoporosis was higher in women with these deformities than in women without. Waterloo et al. reported that prevalent VF in women was associated with back pain and that the severity of fracture was associated with quality of life, using the self-administered questionnaire EQ-5D-3 L.

Studies investigating prevalent VF, identified using VFA, and their association with physical function are lacking, and little is known about associations between mild fractures and clinical outcomes. The primary aim of this population-based cross-sectional study was to investigate if prevalent VF, detected by VFA, was associated with quality of life, back pain and physical function in older women, and if VFA is useful for diagnosing clinically relevant VFs. The secondary aim was to assess if also mild VFs were associated with these clinical parameters.

Subjects and methods {#Sec2}
====================

Subjects {#Sec3}
--------

A cross-sectional population-based study was performed with 3030 women between the ages of 75 to 80 years. Women living in Gothenburg or in nearby suburbs were randomly recruited using information in the Swedish national population register between March 2013 and May 2016. A letter of invitation was sent and women were then contacted by telephone. All of the included women were ambulant and could understand Swedish. A questionnaire regarding medication, disease, back pain and physical activity habits was completed by all the participants and physical function tests were performed. Occurrence of VF was investigated by VFA in a cohort of 1053 women from these 3030 women. Due to extreme scoliosis, inadequate image quality and high body mass index \> 41.0 kg/m^2^ (BMI), 26 women (20, 4, and 2, respectively) were excluded. As a result, the final cohort consisted of 1027 women. All the study participants gave their informed consent and the ethical review board at the University of Gothenburg approved the study. The examinations took place at the Osteoporosis Clinic, at the Geriatric Medicine clinic, Sahlgrenska University Hospital in Mölndal, Sweden.

Physical function tests {#Sec4}
-----------------------

The one-leg standing test (OLS) was performed with eyes opened and arms across the chest \[[@CR19]\]. Women were asked to choose which leg they preferred to start with. Time keeping started when the foot was lifted from the ground with flexed knee and ended when the foot touched the floor again, or the arm moved from the chest, if the weight bearing limb moved or when the time reached 30 s. The test was performed twice and the maximum value was used in the analysis.

The Timed Up and Go (TUG) tests mobility and balance \[[@CR20]\]. From a sitting position in a chair, which was 45 cm high and with armrests, the subject rose and walked three meters in normal pace, turned around, walked back and sat down into the chair again. The time for this procedure was recorded. Participants wore footwear of their own choice and walking aids were allowed if needed. The test was repeated once, but then performed with a glass of water in one hand (TUG manual).

The 30-s chair stand test measures lower body strength \[[@CR21]\]. The subject sat in a chair, 45 cm high, with the wrists crossed against the chest, and on a command "go" the participant rose to standing position and then returned to sitting position and repeated this procedure as many times as possible in 30 s.

The gait velocity was recorded with the timed 10-m walk test \[[@CR22], [@CR23]\]. Each participant was instructed to walk 10 m in a pace they found comfortable. To eliminate the acceleration and deceleration, time keeping started after 2 m and ended at 8 m. The test was repeated twice, and the mean value of the repeated test was recorded in meters per second.

A Saehan hydraulic hand dynamometer (model SH5001; Saehan Corporation, Masan, Korea) was used to measure grip strength in the dominant hand. With the arm resting on a table with the elbow flexed in 90°, two attempts were performed and the average strength, measured in kilogram, was used in the analyses \[[@CR24], [@CR25]\].

Questionnaires {#Sec5}
--------------

A self-reported questionnaire was completed by all the participants including questions regarding medical history, medication, previous fracture, life-style factors influencing the risk of osteoporosis and fractures, health-related quality of life (12-item Short Form Health Survey, SF-12), current physical activity (the Physical Activity Scale for the Elderly, PASE), previous back pain the past 12 months (yes/no), and daily calcium intake.

The SF-12 was developed from the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) to offer a shorter survey taking less time for the participants to answer \[[@CR26]\]. It consists of 12 questions about physical and mental health. The score from SF-12 was weighted and summed and provided a value for physical (Physical Component Summary, PCS) and mental health (Mental Component Summary, MCS) between 0 to 100, where 0 indicates the lowest level of health and 100 indicates the highest level of health.

The PASE questionnaire assesses physical activity, the last 7 days, in persons 65 years and older \[[@CR27]\]. Questions include leisure activities, sport and recreation and are recorded as seldom (1--2 days), sometimes (3--4 days) or often (5--7 days), also taking into account the duration defined as \< 1 h, 1--2 h, 2--4 h or \> 4 h. Housework and lawn work is also included. The total score was computed by multiplying the amount of time spent in each activity (hours/week) or participation (yes/no) in an activity by the empirically derived item weights and summing over all activities.

Daily calcium intake was recorded using a validated questionnaire and was combined with the intake from food with any supplements \[[@CR28]\].

Vertebral fracture assessment {#Sec6}
-----------------------------

Identification of VF from lateral images of the spine, performed by DXA (Discovery A, Hologic, Waltham, MA, USA), with the participant in supine position, was done by using the software program Physician's Viewer (Hologic). To enhance the ability to visualize each vertebra this software provides tools with which you can adjust the greyscale, alter the magnification, brightness and contrast. The fourth lumbar vertebra was marked by the DXA operator. To visualize the shape of each vertebral body, six markers were placed on the vertebras T4--L4 \[[@CR29]\]. One orthopedic surgeon (LJ) analyzed all the 1027 subjects. The fractures were then classified, according to the semi quantitative classification by Genant, as mild, moderate or severe (height reduction 20--25%, \> 25--40% and \> 40%, respectively) \[[@CR30]\]. The type of fracture, wedge, biconcave or crush was also noted. With the presence of scoliosis, there is a risk that a rotated vertebra can be misinterpreted as a biconcave fracture. To assess the presence of scoliosis the lumbar anteroposterior spine image and whole body image were used. Differential diagnosis of other morphologic deformities of vertebral bodies included short vertebral height, Scheuermann's disease, degenerative scoliosis, Schmorl's nodes and Cupid's bow deformity \[[@CR31]\]. When the reproducibility was tested on 50 women (T4--L4), the intraobserver agreement, for vertebras T4--L4, was 98.9% (kappa score 0.85) and the interobserver agreement was 97.6% (kappa score 0.72). When mild VFs were excluded the intraobserver agreement was 100% (kappa score 1.0) and the interobserver agreement 99.6% (kappascore 0.95).

Statistical analyses {#Sec7}
--------------------

Independent *t* tests (for continuous variables) and *χ* ^2^ (for categorical variables) were used when comparing means or proportions between the groups with and without VFs. After dividing the fracture group into number and severity of fractures, one way analysis of variance (ANOVA) followed by least significant difference (LSD) post hoc test, was used to compare means between groups. The results are presented as mean value ± standard deviation. Linear regression models were used, with PCS, MCS and physical function tests as dependent variables, and VF and covariates as independent variables, to investigate the associations between VF and health-related quality of life and physical function with covariates. In these analyses, covariates were age, weight, height, fall accident last year, Parkinson's disease, rheumatoid arthritis, stroke, hypothyroidism, hypertension, cataract, cancer, asthma/bronchitis/emphysema, diabetes, smoking, alcohol, scoliosis and self-reported fracture. PASE was added as covariate and self-reported fracture removed when analyzing physical function tests.

Logistic regression models were used, with back pain as dependent variable and VF and covariates as independent variables, to investigate the associations between VF and back pain with covariates (age, weight, height, fall accident last year, Parkinson's disease, rheumatoid arthritis, stroke, hypothyroidism, cataract, cancer, smoking, alcohol, scoliosis and self-reported fracture). The results are presented as standardized β coefficient and *p* value and odds ratios (OR) with 95% confidence interval (CI) per standard deviation change in each variable. *P* values less than 0.05 were considered significant. All statistical analyses were performed with SPSS Statistics Version 21 (IBM Corporation, Armonk, NY, USA).

Results {#Sec8}
=======

Characteristics of the cohort {#Sec9}
-----------------------------

Characteristics of the cohort divided into having no VF (control group) or increasing numbers of VFs is presented in Table [1](#Tab1){ref-type="table"}. Height at the time for this investigation (but not regarding reported height at the age of 25), self-reported fracture after 50 years of age, usage of osteoporosis medication and glucocorticoids, stroke and self-reported osteoporosis prevalence differed between groups (*p* \< 0.05).Table 1Characteristics of older women without VFA-diagnosed vertebral fracture (VF) and increasing number of vertebral fracturesNo VFOne VFTwo VFsMore than two VFs*p* value^s,t^*N* = 750*N* = 194*N* = 56*N* = 27Age, years77.7 ± 1.677.8 ± 1.477.8 ± 1.477.9 ± 1.40.690Height (cm)162.4 ± 5.9161.4 ± 5.3^§^161.6 ± 6.1159.8 ± 4.9\***0.014**Height at age 25 (cm)165.6 ± 5.6^i^165.5 ± 4.9165.2 ± 5.6166.3 ± 4.80.872Weight (kg)68.5 ± 11.867.8 ± 10.971.2 ± 14.566.3 ± 11.00.193Body mass index (kg/m^2^)26.0 ± 4.326.0 ± 3.827.3 ± 5.125.9 ± 3.90.187Physical activity (PASE)110.3 ± 53.7^j^101.7 ± 45.1^o^110.9 ± 53.4^q^100.5 ± 69.30.181Fall accident last year, % (*n*)29.7 (223)33.0 (64)39.3 (22)37.0 (10)0.366Calcium intake (mg/day)695.5 ± 386.1^k^707.2 ± 414.4708.4 ± 389.3897.9 ± 434.00.075Self-reported fracture, % (*n*)^a^34.7 (259)^k^39.4 (76)^o^60.7 (34)66.7 (18)**\< 0.001**Smoking, % (*n*)^b^6.6 (50)6.2 (12)3.6 (2)7.4 (2)0.827Alcohol, % (*n*)^c^0.1 (1)^l^0.0 (0)0.0 (0)0.0 (0)0.946Pharmacological treatmentGlucocorticoids, previous use, % (*n*)^d^2.3 (17)^m^2.1 (4)^p^7.3 (4)^q^7.7 (2)^r^0.060Glucocorticoids, current\
use % (*n*)^e^2.4 (18)3.1 (6)5.4 (3)11.1 (3)**0.040**Osteoporosis medication, previous use % (*n*)^f^13.1 (98)19.6 (38)29.1 (16)^q^63.0 (17)**\< 0.001**Osteoporosis medication, current use % (*n*)^g^0.1 (36)5.2 (10)17.9 (10)22.2 (6)**\< 0.001**Medical historyParkinson's disease, % (*n*)0.5 (4)0.5 (1)0.0 (0)3.7 (1)0.179Rheumatoid Arthritis, % (*n*)3.3 (25)^n^4.6 (9)1.8 (1)0.0 (0)0.513Stroke, % (*n*)8.3 (62)7.2 (14)3.6 (2)25.9 (7)**0.005**Hypothyroidism, % (*n*)13.3 (99)^k^10.9 (21)^o^19.6 (11)11.1 (3)0.384Osteoporosis, % (*n*)^h^14.4 (108)^l^23.2 (45)32.1 (18)70.4 (19)**\< 0.001**Hypertension, % (*n*)50.4 (378)53.6 (104)70.4 (27)70.4 (19)0.187Cataract, % (*n*)42.5 (319)47.4 (92)53.6 (30)48.1 (13)0.281Cancer, % (*n*)19.3 (145)17.5 (34)12.5 (7)25.9 (7)0.440Values are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables*PASE* Physical Activity Scale for the Elderly^a^After 50 years of age, fracture of hip, vertebra, lower arm/wrist, clavicula/shoulder, proximal humerus, costae, femur, knee, lower leg, ancle/foot/toe, hand/finger^b^Smoking at any time during the last 6 months^c^21 or more units per week (as for FRAX)^d^At least 3 months of their life^e^Usage based on the last 30 days^f^Any usage of bisphosphonate, zoledronic acid, strontiumranelat, parathyroid hormone, denosumab^g^Bisphosphonates and denosumab last month^h^Self-reported from the question "Have the doctor told you that you have osteoporosis?"^i^688^j^747^k^746^l^749^m^726^n^748^o^193^p^188^q^55^r^26^s^Continuous variables one way ANOVA followed by least significant difference post hoc test^t^Categorical variables *χ* ^2^ test, Pearson's chi-square. Significance was defined by a *p* value \< 0.05 and significant values are presented in bold^§^One VF vs. no VF\*More than two VFs vs. no VF

Prevalence of fractures {#Sec10}
-----------------------

In this cohort of 1027 women, the prevalence of having at least one VF was 27% (750 subjects had no VF, 277 had one VF or more). The subjects with VF were divided into having only one VF (*n* = 194), two VFs (*n* = 56) or more than two VFs (*n* = 27). The subjects having mild, moderate or severe VF were 107, 107 and 63, respectively. The frequency and different types of VFs are described in Fig. [1](#Fig1){ref-type="fig"}. There were 406 prevalent VF, of which the most common type was wedge (*n* = 213, 52.5%) followed by biconcave (*n* = 183, 45.1%) and crush (*n* = 10, 2.5%) fracture. When VFs were divided into severity, mild VF was the most common (*n* = 167, 41.1%) followed by moderate (*n* = 156, 38.4%) and severe (*n* = 83, 20.4%).Fig. 1The number of vertebral fractures presented according to different types of fractures and vertebral level (T4--L4)

Vertebral fractures and associations to health-related quality of life and back pain {#Sec11}
------------------------------------------------------------------------------------

The physical health was significantly worse and back pain more common in women with any VF than in controls (43.5 ± 11.3 vs. 46.2 ± 10.5, *p \<* 0.001 and 69.0 vs. 59.9%, *p* = 0.008, respectively). The prevalence of back pain increased with both severity of VF and numbers of prevalent VFs. The proportion of women who reported back pain was 84.1 and 77.8% with prevalent severe VF and more than two VFs, respectively (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}). PCS12 was the lowest for women with more than two VFs (39.0 ± 13.9) and for women with severe VF (40.2 ± 12.6). Also, women with mild VFs had worse physical health (Table [3](#Tab3){ref-type="table"}). In contrast, mental health was not significantly different between the number or severity of VFs compared to controls (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}).Table 2Health-related quality of life, back pain and physical function in relation to number of vertebral fractures (VF)No VF\
*N* = 750VF (any)\
*N* = 277*p* value^a^One VF\
*N* = 194Two VF\
*N* = 56More than two VFs\
*N* = 27ANOVA^A^\
*p* valueSF-12PCS1246.2 ± 10.5^c^43.5 ± 11.3^j^**\< 0.001**43.7 ± 11.1^§o^45.0 ± 10.639.0 ± 13.9\*^\^\#w^**\< 0.001**MCS1254.3 ± 8.5^c^54.7 ± 9.1^j^0.54354.5 ± 8.9^o^55.4 ± 9.454.1 ± 9.7^w^0.810Back pain, % (n)59.9 (449)69.0 (191)**0.008** ^b^67.5 (131)69.6 (39)77.8 (21)**0.042** ^b^FunctionOLS (s)15.3 ± 10.4^d^13.5 ± 10.3^k^**0.030**13.0 ± 10.1^p^15.9 ± 11.1^t^11.8 ± 9.2^×^0.051TUG (s)8.5 ± 2.6^e^9.1 ± 3.2^j^**0.004**9.1 ± 3.4^§o^8.4 ± 2.210.3 ± 3.6\*^\^\#w^**\< 0.001**TUG manual (s)10.1 ± 2.6^f^10.5 ± 2.8^l^**0.027**10.5 ± 2.7^q^10.0 ± 2.312.2 ± 3.8\*^\^\#y^**0.001**Walking speed, (m/s)1.29 ± 0.23^g^1.23 ± 0.26^j^**0.001**1.23 ± 0.25^o^1.29 ± 0.241.10 ± 0.28\*^\^\#w^**\< 0.001**30-s chair stand test, (*n*)11.4 ± 3.4^h^10.7 ± 3.1^m^**0.006**10.6 ± 3.1^§r^11.2 ± 3.1^u^10.5 ± 3.6^z^**0.028**Grip strength (kg)13.4 ± 5.2^i^13.1 ± 5.8^n^0.35813.0 ± 5.6^s^13.8 ± 6.1^v^12.1 ± 6.2^w^0.481Results are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables*PCS* Physical Component Summary, *MCS* Mental Component Summary, *OLS* one-leg standing, *TUG* Timed Up and Go, *TUG manual* Timed Up and Go with a glass of water in one hand. Maximum grip strength is presented for the dominant hand^A^One way ANOVA, followed by least significant difference post hoc test^a^Independent samples *t* test^b^χ^2^ test^c^749^d^613^e^747^f^735^g^745^h^710,^i^729^j^275^k^213^l^267^m^256^n^270^o^193^p^155^q^188^r^182^s^189^t^41^u^53^v^55^w^26^x^17^y^23^z^21^§^One VF vs. no VF\*More than two VFs vs. no VF\^More than two VFs vs. one VF^\#^More than two VFs vs. two VFs. Significance was defined by a *p* value \< 0.05 and significant values are presented in bold Table 3Health-related quality of life, back pain and physical function in relation to severity of VFNo VF\
*N* = 750Mild VF\
*N* = 107Moderate VF\
*N* = 107Severe VF\
*N* = 63ANOVA^A^\
*p* valueSF-12PCS1246.2 ± 10.5^a^43.8 ± 10.9^§^45.3 ± 10.6^k^40.2 ± 12.6\*^\^\#^**\< 0.001**MCS1254.3 ± 8.5^a^54.2 ± 8.3^h^55.1 ± 9.3^k^54.7 ± 10.10.832Back pain, % (*n*)59.9 (449)65.4 (70)63.6 (68)84.1 (53)**0.002** ^B^FunctionOLS (s)15.3 ± 10.4^b^12.7 ± 9.9^§h^15.2 ± 10.5^l^11.8 ± 10.4\*^o^**0.038**TUG (s)8.5 ± 2.6^c^8.5 ± 2.28.8 ± 2.4^i^10.5 ± 5.0\*^\^\#p^**\< 0.001**TUG manual (s)10.1 ± 2.6^d^10.5 ± 2.8^i^10.2 ± 2.6^m^11.1 ± 3.0\*^\#q^**0.027**Walking speed, (m/s)1.29 ± 0.23^e^1.25 ± 0.221.26 ± 0.25^i^1.13 ± 0.30\*^\^\#p^**\< 0.001**30-s chair stand test (*n*)11.4 ± 3.4^f^10.7 ± 3.2^§j^11.0 ± 3.1^n^10.2 ± 2.9\*^r^**0.021**Grip strength, (kg)13.4 ± 5.2^g^13.1 ± 6.0^k^13.6 ± 5.5^i^12.0 ± 5.8^s^0.216Results are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables*PCS* Physical Component Summary, *MCS* Mental Component Summary, *OLS* one-leg standing, *TUG* Timed Up and Go, *TUG manual* Timed Up and Go with a glass of water in one hand. Maximum grip strength is presented for the dominant hand^A^One way ANOVA, followed by least significant difference post hoc test^B^ *χ* ^2^ test was used. Significance was defined by a *p* value \< 0.05 and significant values are presented in bold^a^749^b^613^c^747^d^735^e^745^f^710^g^729^h^90^i^106^j^102^k^105^l^79^m^104^n^101^o^44^p^62^q^57^r^53^s^59^§^Mild VF vs. no VF\*Severe VF vs. no VF^\^^Severe VF vs. mild VF^\#^Severe VF vs. moderate VF

The association between VF prevalence with PCS and MCS with covariates was investigated using linear regression models (Table [4](#Tab4){ref-type="table"}). In these models, all three groups of VFs (any, number, and severity) were independently associated with physical health (β = − 0.079, *p* = 0.007, and β = − 0.083, *p* = 0.005, and β = −0.091, *p* = 0.002, respectively). Mental health was not independently associated with VF regardless of VF number or severity (Table [4](#Tab4){ref-type="table"}).Table 4Association between health-related quality of life and physical function and vertebral fracture (VF) number and severity in older womenVF (no/yes)Number of VFSeverity of VFβ*p* valueβ*p* valueβ*p* valueSF-12PCS− 0.079**0.007**− 0.083**0.005**− 0.091**0.002**MCS0.012ns0.015ns0.019nsFunction^a^OLS (s)− 0.042ns− 0.027ns− 0.034nsTUG, (s)0.067**0.021**0.067**0.020**0.109**\< 0.001**TUG manual (s)0.041ns0.059**0.043**0.043nsWalking speed, (m/s)− 0.071**0.009**− 0.078**0.004**− 0.096**\< 0.001**30-s chair stand test (*n*)− 0.075**0.012**− 0.057ns− 0.075**0.013**Grip strength (kg)0.008ns0.007ns− 0.001nsLinear regression models were used to investigate associations between HRQL and physical function, as dependent variables, and VF and covariates (age, weight, height, fall accident last year, Parkinson's disease, rheumatoid arthritis, stroke, hypothyroidism, hypertension, cataract, cancer, asthma/bronchitis/emphysema, diabetes, smoking, alcohol, scoliosis, self-reported fracture), as independent variables. The results are presented as standardized β coefficients (SD change in the dependant variable per SD change in the independent variable) and *p* values. Significance was defined by a *p* value \< 0.05 and significant values are presented in bold*PCS* Physical Component Summary, *MCS* Mental Component Summary, *OLS* one-leg standing, *TUG* Timed Up and Go, *TUG manual* Timed Up and Go with a glass of water in one hand. Maximum grip strength is presented for the dominant hand^a^PASE included as covariate and self-reported fracture not included

To investigate the association between back pain and VFs, independently of covariates, logistic regression models were used. All three groups of VFs (any, number, and severity) were independently associated with back pain (Odds Ratio (OR) 1.44 \[1.06--1.95\], OR 1.29 \[1.06--1.58\] and OR 1.27 \[1.09--1.48\], respectively) (Table [5](#Tab5){ref-type="table"}).Table 5Association between back pain and vertebral fracture (VF) number and severity in older womenVF (no/yes)Number of VFSeverity of VFOR (95% CI)OR (95% CI)OR (95% CI)Back pain,\
yes/no^a^**1.44 (1.06 to 1.95)1.29 (1.06 to 1.58)1.27 (1.09 to 1.48)**Logistic regression models were used to investigate associations between back pain, as dependent variable, and VF and covariates (age, weight, height, fall accident last year, Parkinson's disease, rheumatoid arthritis, stroke, hypothyroidism, cataract, cancer, smoking, alcohol, self-reported fracture, scoliosis), as independent variables. The results are presented as OR with 95% CI per SD decreaseSignificance was defined by a *p* value \< 0.05 and significant values are presented in bold^a^Self-reported from the question "Have you had back pain the past 12 months?

Vertebral fractures and associations to physical function {#Sec12}
---------------------------------------------------------

Physical function tests OLS, TUG, TUG manual, walking speed and 30 s chair stand test were significantly inferior in women with VF compared to controls, while grip strength was not different (Table [2](#Tab2){ref-type="table"}). A similar pattern was seen when severity of VF was compared to controls (Table [3](#Tab3){ref-type="table"}). When comparing frequency of VF to controls, OLS and grip strength were not significantly different than in women without VFs (Table [2](#Tab2){ref-type="table"}). Linear regression models were used to investigate the associations between physical function and VF with covariates (Table [4](#Tab4){ref-type="table"}). In these analyses, increasing number and severity of VFs were independently associated with longer TUG and reduced walking speed (Table [4](#Tab4){ref-type="table"}). The number of VFs was independently associated to TUG manual. Having any VF was independently associated to a worse outcome in the 30 s chair stand test. OLS and grip strength was not independently associated with VF (Table [4](#Tab4){ref-type="table"}).

The associations between VF and physical health and physical function were also adjusted for back pain in the linear regression model. All significant associations between PCS and physical function measures and VF prevalence in Table [4](#Tab4){ref-type="table"} remained significant (*p* \< 0.05) also after additional adjustment for back pain (data not shown).

Vertebral fractures at the thoracolumbar junction {#Sec13}
-------------------------------------------------

We divided the cohort into women with any VF in the thoracolumbar junction (Th12--L1; *n* = 105), women with any VF in other vertebra (*n* = 172) and women without VF (*n* = 750). Using ANOVA with LSD post hoc test, women with any VF at the thoracolumbar junction had lower PCS (41.5 ± 11.9, 44.8 ± 10.8, 46.2 ± 10.5, ANOVA *p* \< 0.001), reduced physical function (TUG 9.6 ± 3.0, 8.8 ± 3.4, 8.5 ± 2.6 s, *p* = 0.001; walking speed 1.18 ± 0.26, 1.26 ± 0.25, 1.29 ± 0.23 m/s, *p* = \<0.001) than women with any VF at other levels and women without VF, respectively. History of back pain was more common in women with VF in the thoracolumbar junction (*n* = 80, 76.2%) than in women with VF in other vertebras (*n* = 111, 64.5%) and in women without VFs (449 (59.9%), respectively (*p* = 0.004)).

Discussion {#Sec14}
==========

In this population-based cross-sectional study of ambulant older women, we found that prevalent VFA diagnosed VF number and severity were independently associated to physical health (PCS SF-12), back pain and physical function (TUG, walking speed and 30-s chair stand test). Interestingly, also mild VFs were associated with reduced physical function and physical health, indicating that these fractures are also clinically relevant to diagnose. To our knowledge this is the first study investigating associations between physical function, assessed by multiple, validated performance-based measures, and prevalent VF identified using VFA.

Hall et al. investigated the quality of life and functional impairment in 100 women with VF, diagnosed using spine radiographs, and 100 matched controls from the community. In this case-control study the women with VF had worse physical function compared to controls assessed by 3 m TUG (13.8 ± 7.3 s vs. 10.1 ± 4.1, *p* = \<0.01) \[[@CR32]\]. In a cohort study of community-dwelling women, aged 60 years and over with VFs, Morris et al. investigated if balance tests could predict falls \[[@CR33]\]. Several indices, including the 5 m-TUG test, timed 10-m walk and the TURN180 test, reflecting poor balance, were associated with falls. After multivariable analyses, they found that the best test to predict falls in older women with VF was the TUG test. In the present study, TUG was independently associated with VF. This data supports the concept that TUG could be a useful tool in the clinical setting to measure physical mobility and balance in women with VF, in order to choose appropriate interventions to reduce falls. Further studies are needed to validate cut-off points for TUG in women with VF.

Lower grip strength in men and women with VF than in controls has been reported from the MrOS and MsOS study from Hongkong performed by Kwok et al. \[[@CR34]\]. After adjustments with covariates, a lower grip strength remained associated to prevalent VF among men but not among women. In the present study, we did not find any associations between VF and grip strength.

In the case-control study by Hall et al., the physical and mental component summary indexes of the SF-36 were lower in the VF group than in controls, and the PCS differed more than the MCS (PCS 36 ± 11 vs. 48 ± 9, *p* = \<0.001, MCS 50 ± 11 vs. 54 ± 8, *p* = \<0.05, respectively) \[[@CR32]\]. In our cohort, we also found a lower PCS (SF-12) in the VF group compared to controls, while the mental health did not show any significant difference between groups (Table [2](#Tab2){ref-type="table"}). The association between VF, assessed by conventional spine radiographs, and SF-12 was previously investigated among 804 women. Mild and moderate/severe VFs were associated with inferior scores in SF-12 PCS (non-adjusted analysis) but not in MCS. In multivariable regression analyses lower PCS scores were associated to prevalent VF \[[@CR35]\]. These findings are in concordance with our results, which revealed independent significant associations between PCS, not only to severity of VF, but also to number of VF (Table [4](#Tab4){ref-type="table"}). Similar results were seen in the Tromsø Study, in which quality of life was measured using EQ-5D-3 L \[[@CR18]\]. In women, after adjustments, EQ-5D-3 L and back pain were associated with prevalent number and severity of VF, verified by VFA.

Our secondary aim was to investigate the clinical importance of identifying mild fractures. When interpreting the relevance of mild VF it is of importance to take into account that non-fracture deformities due to degenerative disease, a condition common in older people, can be misinterpreted as a VF. Awareness of identification of typical signs of osteoarthritis as osteophytes, narrow disc spaces and lower anterior height is necessary. One way to distinguish wedge deformation due to osteoporosis, from osteoarthritis, is that not only the anterior/posterior height ratio is lower but also the mid/posterior vertebral height ratio \[[@CR36]\]. The latter was also considered in this study. By using Genant semi-quantitative classification, in which a mild fracture is defined by a height reduction of 20--25%, we have taken into consideration the well accepted cutoff of 20% height reduction to avoid inclusion of non-fracture deformities \[[@CR31]\]. The importance of diagnosing mild fractures can be explained by the vertebral fracture cascade. With the presence of a VF (all grades of severity) comes changes in spinal biomechanics, due to disc degeneration and bone loss, with increased loading on adjacent vertebra giving an increased risk of incident VF \[[@CR37]\]. Roux et al. followed 2551 postmenopausal women with osteoporosis for 4 years. VFs were diagnosed by spine radiographs. They found that mild VF was a risk factor for subsequent VF during a 4-year period (RR 1.8, *p* = \<0.001) \[[@CR38]\]. Although this vertebral fracture cascade is a known phenomenon, most studies investigating VFs and their associations with physical health and function have focused on grade 2 and 3 VFs \[[@CR39]\]. The prevalence of mild VF in our material (41.1%) was similar to the prevalence of minor vertebral deformities found by Kanterewicz et al. (39.3%), using McCloskey criteria and Lunar DXA equipment \[[@CR17]\]. We found that mild VFs were associated not only with reduced physical health (SF-12), but also with inferior physical function. In recent studies, VFA has been described as a valuable method to detect grades 2 and 3 VFs \[[@CR14]--[@CR16]\]. We hypothesize that VFA should be considered a valuable method also for diagnosing mild VF, since these fractures most likely contribute to the vertebral fracture cascade and are associated with physical health and function.

A limitation in this study is that a causal relationship cannot be assured with this cross-sectional design. Another limitation is that the VFA identified VF were not validated against spine radiography in this cohort. When interpreting results from generic health status questionnaires, an identified statistically significant difference does not always constitute a clinically relevant difference. The minimal clinically important difference (MCID) of SF-12 in patients with subacute and chronic low back pain was reported to be 3.3 or greater, in PCS \[[@CR40]\]. In this study, the difference in PCS between women with and without any VF was 2.7, indicating that this difference was just below being clinically important. However, when comparing PCS in women without VF and women having more than two VFs, the difference in PCS was 7.2, which is more than twice the MCID. To our knowledge there are to date no studies concerning MCID for PCS in people with VF.

One of the strengths in this study is that all the VFA analyses were performed by one operator. Another strength is that the cohort is the so far largest to investigate VF, identified using VFA, and the relation to physical function, assessed by multiple performance-based measures. The population-based design in this study, compared to case-control studies, reduces the risk of confounding bias from recent prior fracture and large differences in anthropometrics and morbidity.

In conclusion, in this cross-sectional population-based study of older women, we found that prevalent VF, diagnosed by VFA, was associated with worse physical health, increased prevalence of back pain and reduced physical function. These findings support the use of VFA in order to identify frailty due to VF of all severity.
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